|
KMID : 0379520040200010083
|
|
한국독성학회지
2004 Volume.20 No. 1 p.83 ~ p.88
|
|
|
5-Day Repeated Intravenous Dose Toxicity Study of a New Camptothecin Anticancer Agent CKD-602 in Rats
|
|
Kim Jong-Choon
Shin Dong-Ho
Kim Seong-Ho
Bae Chun-Sik
Kim Joon-Kyum
Cha Shin-Woo
Han Jung-Hee
Lee Hyun-Sook
Chung Moon-Koo
|
|
|
Abstract
|
|
|
|
The present study was carried out to investigate the potential adverse effects of CKD-602 by a 5-day repeated intravenous dose in Sprague-Dawley rats. The test article, CKD-602, was administered intravenously to male and female rats at dose levels of 0.07, 0.22, 0.67, 2.0 and 6.0 mg/kg/day for 5 days consecutively. Mortalities, clinical findings, and body weight changes were monitored for the 14-day period after cessation of the administration. At the end of 14-day observation period, all animals were sacrificed and complete gross postmortem examinations were performed. There were 2 and 5 treatment related deaths in the 0.67 and 2.0 mg/kg/day dose groups of both genders, respectively. Treatment related clinical signs, including hair loss, skin paleness, decreased locomotor activity, emaciation, and changes in stool were observed in a dose-dependent manner from the third day after initiation of the injection. Decrease or suppression of body weight was also observed dose-dependently in males and females of the treated groups. Gross postmortem examinations revealed a dose-dependent increase in the incidence and severity of atrophy or hypertrophy and white membrane formation in the spleen, atrophy of the thymus, diffuse white spots and paleness of the liver, paleness of the lung, kidney and adrenal gland, and dark red discoloration and dark red contents in the alimentary tract. Based on these results, it was concluded that the 5-repeated intravenous injection of CKD-602 to male and female rats resulted in increased incidence of abnormal clinical signs and death, decreased or suppressed body weight, and increased incidence of abnormal gross findings. In the present experimental conditions, the LD_{50} value was 2.07 (95% confidence limit not specified) mg/kg/day in both genders and the LD_{10} value was 1.72 (95% confidence limit not specified) mg/kg/day in both genders.
|
|
|
KEYWORD
|
|
|
Anticancer agent, CKD-602, Camptothecin, Repeated dose toxicity, LD_{50} value, Rats.
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
 
|
|